Funding

Ionic Pharmaceuticals is supported by private investment as well as non-dilutive Government Grants. Please contact us if you are interested in partnering with Ionic Pharmaceuticals.

Drug Delivery

National Institutes of Health (NIH) Small Business Innovation Research (SBIR) support for this project comes from the National Cancer Institute (NCI) and includes:

Phase II SBIR: 2 R44 CA189215-02A1 (2019)

                       $2,000,000

Phase I SBIR: 1 R43 CA224739-01A1 (2018)

                       $296,990

Phase I SBIR: 1 R43 CA213538-01A1 (2017)

                       $283,122

Phase I SBIR: 1 R43 CA189215-01 (2014)

                       $224,715

Total NIH Funding: $2.8M

Wound Care

NIH SBIR support for this project comes from the National Institute of General Medical Sciences (NIGMS) and includes:

Phase I SBIR: 1 R43 GM125412-01 (2019)

                       $224,715

Total NIH Funding: $225K

189 Tappan Street

Brookline, MA

02445

For more information, please e-mail:

info@ionicpharma.com

© 2020 by Ionic Pharmaceuticals, LLC